Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.6.4 (
chondroitinase
)
2,039
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The amino acid sequence of
interferon gamma
(
IFN-gamma
) has basic amino acid clusters similar to the heparin-binding consensus sequences found in other proteins that bind to proteoglycans (PGs). We investigated whether recombinant human
IFN-gamma
could bind to extracellular matrix (ECM) PGs secreted by human arterial smooth muscle cells (HASMCs) in vitro and whether the interaction affected the cellular response to
IFN-gamma
. As an in vitro model of ECM we used the basement membrane from HASMCs in culture. The binding of 125I-
IFN-gamma
to ECM was reduced significantly by pretreatment of ECM with
chondroitinase
ABC, an enzyme that degrades chondroitin-sulfate glycosaminoglycans.
IFN-gamma
binding to ECM was reduced by increasing concentrations of chondroitin-6-sulfate. 125I-
IFN-gamma
(0.05 to 2 ng/mL) binding data indicated an apparent Kd of 2 x 10(-11) mol/L and a maximum binding of 1.6 x 10(6)
IFN-gamma
molecules bound per square millimeter of ECM. Experiments with synthetic peptides suggested that residues 127 through 135 (AKTGKRKRS) are involved in the binding. The binding to chondroitin-sulfate PGs was confirmed by affinity chromatography of isolated [35S]chondroitin-sulfate PGs from ECM and cell-culture medium on immobilized
IFN-gamma
. The binding was abolished by treatment with
chondroitinase
ABC. ECM-bound
IFN-gamma
was more effective in inducing the expression of class II major histocompatibility antigens such as HLA-DR in HASMCs and human arterial endothelial cells than soluble
IFN-gamma
. These results suggest a role for chondroitin-sulfate PGs in immobilizing
IFN-gamma
in the ECM compartment and enhancing the cellular response to
IFN-gamma
.
...
PMID:Interferon gamma binds to extracellular matrix chondroitin-sulfate proteoglycans, thus enhancing its cellular response. 767 Sep 61